Free tool
FAERS Monitor: Augmentin Xr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050785 or its brand name (Augmentin Xr, Amoxicillin, Clavulanate Potassium). Reports on generic versions are filed under their own applications.
Reports
4,398
Serious
3,700
84% of reports
Hospitalization
2,007
Death reported
431
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea357
- dyspnoea356
- pyrexia257
- drug ineffective242
- nausea241
- fatigue237
- pneumonia225
- pruritus223
- rash218
- pain214
- vomiting208
- headache194
- cough187
- asthma179
- condition aggravated178
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 131 |
| 2005 | 139 |
| 2006 | 41 |
| 2007 | 45 |
| 2008 | 68 |
| 2009 | 302 |
| 2010 | 370 |
| 2011 | 451 |
| 2012 | 393 |
| 2013 | 9 |
| 2014 | 57 |
| 2015 | 143 |
| 2016 | 205 |
| 2017 | 206 |
| 2018 | 326 |
| 2019 | 260 |
| 2020 | 237 |
| 2021 | 165 |
| 2022 | 171 |
| 2023 | 162 |
| 2024 | 203 |
| 2025 | 192 |
| 2026 | 121 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,761 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| asthmaSignal | 179 | 7.6 | 6.6 | 1,021 |
| pyrexiaSignal | 257 | 3.6 | 3.2 | 477 |
| pneumoniaSignal | 225 | 3.3 | 2.9 | 369 |
| coughSignal | 187 | 3.2 | 2.8 | 283 |
| dyspnoeaSignal | 356 | 3.0 | 2.7 | 488 |
| condition aggravatedSignal | 178 | 2.8 | 2.4 | 207 |
| pruritusSignal | 223 | 2.8 | 2.4 | 256 |
| diarrhoeaSignal | 357 | 2.6 | 2.4 | 375 |
| rashSignal | 218 | 2.4 | 2.1 | 179 |
| vomitingSignal | 208 | 2.1 | 1.9 | 124 |
| pain | 214 | 1.7 | 1.5 | 58 |
| headache | 194 | 1.5 | 1.3 | 31 |
| nausea | 241 | 1.5 | 1.3 | 35 |
| fatigue | 237 | 1.5 | 1.3 | 35 |
| drug ineffective | 242 | 0.9 | 0.8 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.